Zdrowie i gospodarka · 26/09/2018

FDA Releases Guidance on Compounding and Repackaging of Radiopharmaceuticals

The FDA has announced the availability of a guidance document outlining its policy on the compounding and repackaging of radiopharmaceuticals by state-licensed nuclear pharmacies, federal facilities, and other entities with a radioactive materials license, to provide clarity on when the agency will not take enforcement action for certain violations.